| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 335 |
| 1 | METHOTREXATE | 295 |
| 2 | CARBOPLATIN | 223 |
| 3 | PEMETREXED DISODIUM | 179 |
| 4 | PREDNISONE | 178 |
| 5 | ETANERCEPT | 163 |
| 6 | LENALIDOMIDE | 153 |
| 7 | PREDNISOLONE | 151 |
| 8 | PREDNISOLONE ORAL | 151 |
| 9 | PREDNISOLONE ORAL SOLUTION | 151 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEMECLOCYCLINE | 5 | 0.0219 |
| 1 | SOTORASIB | 52 | 0.0150 |
| 2 | CERITINIB | 32 | 0.0134 |
| 3 | BARICITINIB | 39 | 0.0128 |
| 4 | APADAMTASE ALFA | 1 | 0.0127 |
| 5 | DACOMITINIB | 9 | 0.0120 |
| 6 | BRIGATINIB | 41 | 0.0112 |
| 7 | METHENAMINE MANDELATE | 2 | 0.0107 |
| 8 | GUAIFENESIN AND DEXTROMETHORPHAN HBR | 1 | 0.0105 |
| 9 | CRIZOTINIB | 87 | 0.0068 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 505 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 431 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 370 |
| 3 | Kinase Inhibitor [EPC] | 319 |
| 4 | Platinum-based Drug [EPC] | 310 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 277 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 173 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 173 |
| 8 | Proton Pump Inhibitor [EPC] | 170 |
| 9 | Vitamin C [EPC] | 160 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 11 | 0.0160 |
| 1 | Actinomycin [EPC] | 7 | 0.0032 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 17 | 0.0029 |
| 3 | Provitamin D2 Compound [EPC] | 67 | 0.0023 |
| 4 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 5 | Blood Viscosity Reducer [EPC] | 8 | 0.0018 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 173 | 0.0018 |
| 7 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 21 | 0.0015 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 3 | 0.0013 |
| 9 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 8 | 0.0013 |